checkAd

     430  0 Kommentare SuperSonic Imagine Announces Clinical Data From Its Retrospective Multicenter Trial Evaluating ShearWave(TM) Elastography for the Non-Invasive Staging of Patients With Chronic Liver Disease - Seite 4

    For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

    Contact information:
    SuperSonic Imagine
    Marketing & Communication
    Emmanuelle Vella
    emmanuelle.vella@supersonicimagine.com
    04 86 79 03 27

    NewCap
    Investor Relations - EU
    Pierre Laurent / Florent Alba
    supersonicimagine@newcap.fr
    +33 1 44 71 98 55

    Blueprint Life Science Group
    Investor Relations - US
    Candice Knoll
    cknoll@bplifescience.com
    415 375 3340 Ext. 105

    ComCorp
    Media Relations
    Florence Portejoie
    fportejoie@comcorp.fr
    +33 1 58 18 32 58 - +33 6 88 84 81 74
    Adelaide Manester
    amanester@comcorp.fr
    +33 1 58 18 32 58 - +33 6 70 45 74 37

    Seite 4 von 4





    Verfasst von Marketwired
    SuperSonic Imagine Announces Clinical Data From Its Retrospective Multicenter Trial Evaluating ShearWave(TM) Elastography for the Non-Invasive Staging of Patients With Chronic Liver Disease - Seite 4 AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 28, 2015) - SuperSonic Imagine (EURONEXT PARIS: SSI) (Euronext: SSI, FR0010526814) whose ShearWave Elastography™ (SWE™) and Ultrafast™ Doppler technologies have revolutionized the ultrasound imaging …